nejm semaglutide heart failure New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj Oral and Cardiovascular Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis In patients with type 2

Lipo C (216 mg) Research-Grade Lipotropic Compound Blend Tagline: Metabolic & Lipid Mobilization Research Formula Product Description Lipo C is a lipotropic compound blend composed of Methionine, Inositol, Choline, and L-Carnitine , designed for research into fat metabolism, hepatic function, and energy production

BPC-157 + TB-500 Dosage Guide When using the combination of BPC-157 and TB-500, researchers are advised to follow dosage guidelines for effective usage

Noom Med with Smart Rx addresses this urgent problem by rewiring the GLP-1 supply chain to bypass traditional pharmacy benefit managers (PBMs), helping members access medications more efficiently and at the lowest cost

Notably, the study found that once-daily oral semaglutide was associated with lower HbA1c levels and 12-month weight loss across diverse age groups, including adults aged 75 years and older